The recognition of foreign drug certificates in Russia should be based on the principles of reciprocity. This was announced by Elena Maksimkina, the Head of the Department of Drug Supply and Regulation of Medical Devices.
The Ministry of Health of the Russian Federation announced the results of the tender for supply of dasabuvir/ombitasvir/paritaprevir/ritonavir, a new drug for hepatitis C. As it was expected, the declared winner was R-Pharm.
Russian Ministry of Health completed its work on the bill to amend the Federal Law “On Circulation of Medicines” which provides, in particular, for the establishment of a register of interchangeable drugs.
The Russian Ministry of Health will purchase a blood plasma product from Nacimbio, a subsidiary of Rostec Corporation, for more than 1 billion rubles following two auctions held by the Ministry for supply of this medicine.
AbbVie announced that the Russian Ministry of Health approved Venclexta (venetoclax), a drug, for oral administration. The drug is a potent selective inhibitor of antiapoptotic protein of B-cell lymphoma.
For incomplete or distorted provision of details, which caused harm to the life or health of citizens, the draft law establishes the administrative liability in the form of a fine ranging from one million to five million rubles.
WHO announced a high-level commission, comprised of heads of state and ministers, leaders in health and development The group will propose innovative solutions to accelerate prevention and control of noncommunicable diseases.
The Russian Ministry of Health began to prepare a draft law on amendments to the Criminal Code of the Russian Federation in order to fight the circulation of falsified, counterfeit, substandard, and unregistered medicinal products.